NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc.NeuroBo Pharmaceuticals, Inc.

NeuroBo Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

26.670.000.00%
The 3 analysts offering 1 year price forecasts for NRBO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 2 analysts giving stock ratings to NRBO in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


NRBO EPS for the last quarter is −0.55 USD despite the estimation of −0.82 USD. In the next quarter EPS is expected to reach −0.49 USD. Track more of NeuroBo Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter NeuroBo Pharmaceuticals, Inc. revenue is expected to reach 0.00 USD. Check out NeuroBo Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, NRBO price target is 26.67 USD with a max estimate of 48.00 USD and a min estimate of 10.00 USD. Check if this forecast comes true in a year, meanwhile watch NeuroBo Pharmaceuticals, Inc. stock price chart and keep track of the current situation with NRBO news and stock market news.